CN103520693B - Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris - Google Patents
Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris Download PDFInfo
- Publication number
- CN103520693B CN103520693B CN201310501937.2A CN201310501937A CN103520693B CN 103520693 B CN103520693 B CN 103520693B CN 201310501937 A CN201310501937 A CN 201310501937A CN 103520693 B CN103520693 B CN 103520693B
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- grams
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 201000010874 syndrome Diseases 0.000 title claims abstract description 20
- 239000003814 drug Substances 0.000 title claims abstract description 19
- 206010002383 Angina pectoris Diseases 0.000 title claims abstract description 15
- 210000000582 Semen Anatomy 0.000 claims abstract description 19
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 7
- 235000008434 ginseng Nutrition 0.000 claims abstract description 7
- 235000005035 ginseng Nutrition 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 3
- 210000004072 Lung Anatomy 0.000 claims description 21
- 210000000038 chest Anatomy 0.000 claims description 15
- 230000000414 obstructive Effects 0.000 claims description 13
- 241000208340 Araliaceae Species 0.000 claims description 6
- 241000237636 Pheretima Species 0.000 claims description 6
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 6
- 239000012567 medical material Substances 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 26
- 239000002994 raw material Substances 0.000 abstract description 2
- 244000144725 Amygdalus communis Species 0.000 abstract 1
- 235000011437 Amygdalus communis Nutrition 0.000 abstract 1
- 241000758794 Asarum Species 0.000 abstract 1
- 241000512000 Asclepias curassavica Species 0.000 abstract 1
- 241000092665 Atractylodes macrocephala Species 0.000 abstract 1
- 241000202726 Bupleurum Species 0.000 abstract 1
- 240000004499 Cinnamomum aromaticum Species 0.000 abstract 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 abstract 1
- 240000005389 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000243684 Lumbricus Species 0.000 abstract 1
- 241000237502 Ostreidae Species 0.000 abstract 1
- 240000004678 Panax pseudoginseng Species 0.000 abstract 1
- 241001522129 Pinellia Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 240000006023 Trichosanthes kirilowii Species 0.000 abstract 1
- 235000009818 Trichosanthes kirilowii Nutrition 0.000 abstract 1
- 240000007329 Zingiber officinale Species 0.000 abstract 1
- 235000006886 Zingiber officinale Nutrition 0.000 abstract 1
- 235000020224 almond Nutrition 0.000 abstract 1
- 235000008397 ginger Nutrition 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 235000014063 licorice root Nutrition 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- 239000000463 material Substances 0.000 abstract 1
- 235000020636 oyster Nutrition 0.000 abstract 1
- 201000010099 disease Diseases 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 230000001737 promoting Effects 0.000 description 6
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 230000002269 spontaneous Effects 0.000 description 5
- 210000004369 Blood Anatomy 0.000 description 4
- 208000000059 Dyspnea Diseases 0.000 description 4
- 206010013975 Dyspnoeas Diseases 0.000 description 4
- 206010016256 Fatigue Diseases 0.000 description 4
- 210000000952 Spleen Anatomy 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000008187 granular material Substances 0.000 description 4
- 238000000227 grinding Methods 0.000 description 4
- 238000010792 warming Methods 0.000 description 4
- 241000668709 Dipterocarpus costatus Species 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 230000001717 pathogenic Effects 0.000 description 3
- 230000025627 positive regulation of urine volume Effects 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000035900 sweating Effects 0.000 description 3
- 208000006673 Asthma Diseases 0.000 description 2
- 210000001124 Body Fluids Anatomy 0.000 description 2
- 210000000481 Breast Anatomy 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 208000002173 Dizziness Diseases 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010021079 Hypopnoea Diseases 0.000 description 2
- 210000003734 Kidney Anatomy 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 210000003802 Sputum Anatomy 0.000 description 2
- 210000002784 Stomach Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 230000001105 regulatory Effects 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 210000001185 Bone Marrow Anatomy 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000003067 Myocardial Ischemia Diseases 0.000 description 1
- 240000008962 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037211 Psychomotor hyperactivity Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 230000003213 activating Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000146 antalgic Effects 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 230000003110 anti-inflammatory Effects 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 230000002612 cardiopulmonary Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000003419 expectorant Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 230000002607 hemopoietic Effects 0.000 description 1
- 230000001709 ictal Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000009114 investigational therapy Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000036651 mood Effects 0.000 description 1
- 230000002107 myocardial Effects 0.000 description 1
- 230000001662 opsonic Effects 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N p-acetaminophenol Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling Effects 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 230000003068 static Effects 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000004206 stomach function Effects 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000002522 swelling Effects 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Abstract
The invention discloses a traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris. The traditional Chinese medicine is characterized by being a traditional Chinese medicinal preparation made of the following medicinal materials in parts by weight: 3-5 parts of asarum, 8-10 parts of ginseng, 8-10 parts of cassia twig, 12-15 parts of radix ophiopogonis, 8-10 parts of fructus schizandrae, 25-30 parts of trichosanthes kirilowii maxim, 8-10 parts of atractylodes macrocephala koidz, 25-30 parts of poria cocos, 8-10 parts of almond, 8-10 parts of platycodon grandiflorum, 8-10 parts of pinellia ternate, 15-18 parts of semen lepidii, 10-12 parts of radix stephaniae tetrandrae, 8-10 parts of dried ginger, 25-30 parts of oyster, 12-15 parts of Paniculate Swallowwort Root, 8-10 parts of lumbricus, 3-5 parts of liquorice, 8-10 parts of bupleurum, 8-10 parts of fructus amomi, 8-10 parts of cortex mori radicis and 18-20 parts of salviae miltiorrhizae. According to the traditional Chinese medicine, the multiple raw materials are organically combined together, mutually intercoordinate with one another and interact with each other; the traditional Chinese medicine can treat both symptoms and root causes of the heart-lung qi-deficiency syndrome type angina pectoris, is good in effect and can treating the syndrome fundamentally.
Description
Technical field the present invention relates to a kind of Chinese medicine, particularly a kind of Chinese medicine for the treatment of QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia.
A kind of disease that background technology obstruction of qi in the chest and cardialgia ictally to be felt oppressed with Danzhong or left chest, pain is main clinical manifestation, the accidental of short duration slight chest oppressiveness of the lighter or dull pain, or be ictal Danzhong or the unclean sense of discomfort of left breast, severe one sharp ache, or in squeezing sample angor, normal with cardiopalmus, breathe hard, hypopnea, the symptoms such as even dyspnea with rapid and short breath, terrified uneasiness, pale complexion, cold spontaneous sweating.Clinical common pattern of syndrome is syndrome of deficiency of lung qi, syndrome of static blood blocking collaterals, deficiency of heart-QI card, deficiency of heart-blood card, syndrome of disharmony between heart and kidney etc. intentionally.What the present invention mainly studied is one of clinical common pattern of syndrome
---qI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia, the obstruction of qi in the chest and cardialgia that this pattern of syndrome system causes because cardiopulmonary two visceral-qi is empty, the main breathing of lung, heart governing blood and vessels, often, pale tongue with white fur, deep and weak pulse timid with shortness of breath and fatigue, clear and thin sputum, dizziness and fatigue, spontaneous perspiration sound or knot generation etc. symptom.At present, this disease of western medical treatment takes the mode taking analgesic drug product more, and cure the symptoms, not the disease, side effect is very big.
Summary of the invention the object of the invention is the Therapeutic Principle according to " invigorating heart and lung ", a kind of Chinese medicine treating QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia is provided, this Chinese medicine is adopted not only to cure speed fast, more no longer recur after, the effect for the treatment of both the principal and secondary aspects of a disease can be reached, and without any side effects, also have good opsonic action to healthy.
For realizing above-mentioned purpose of the present invention, the technical scheme adopted is: a kind of Chinese medicine for the treatment of QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia, it is characterized in that the Chinese medicine preparation be made up of the medical material of following weight proportion: Herba Asari 3-5 parts, Radix Ginseng 8-10 parts, Ramulus Cinnamomi 8-10 parts, Radix Ophiopogonis 12-15 parts, Fructus Schisandrae Chinensis 8-10 parts, Fructus Trichosanthis 25-30 parts, the Rhizoma Atractylodis Macrocephalae 8-10 parts, 25-30 parts, Poria, 8-10 parts, Semen Armeniacae Amarum, Radix Platycodonis 8-10 parts, the Rhizoma Pinelliae 8-10 parts, Semen Lepidii (Semen Descurainiae) 15-18 parts, Radix Stephaniae Tetrandrae 10-12 parts, Rhizoma Zingiberis 8-10 parts, Concha Ostreae 25-30 parts, Radix Cynanchi Paniculati 12-15 parts, Pheretima 8-10 parts, 3-5 parts, Radix Glycyrrhizae, Radix Bupleuri 8-10 parts, Fructus Amomi 8-10 parts, Cortex Mori 8-10 parts, Radix Salviae Miltiorrhizae 18-20 parts.Processing technique of the present invention is: various medical material grinding is become end, then uses conventional method " whole part " to extract and makes instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserves in shady and cool, dry place.Dissolve with boiled water after meal and take, have part insoluble matter to be normal phenomenon, under all taking after mixing, twice on the one (morning and evening is each once), each one bag 7 days is a course for the treatment of.Period in a medicine, avoids tobacco and wine, raw meat, cold, peppery food, and keep good work and rest custom, association rationally reduces pressure, and actively participates in outdoor activity, loosens mood, avoid staying up late as far as possible.
Effect that Herba Asari of the present invention has heart tonifying, resists myocardial ischemia; The Radix Ginseng adopted can improve myocardial contraction, and has protection and stimulation to the hemopoietic function of bone marrow; The Ramulus Cinnamomi adopted has effect of promoting the flow of QI-blood by warming the meridian, activating YANG and prormoting functioning of QI; The effect that Radix Ophiopogonis has YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire adopted; The Fructus Schisandrae Chinensis adopted have astringe the lung, nourishing kidney, the effect of promoting the production of body fluid; Effect that the Fructus Trichosanthis adopted has lung moistening, reduces phlegm; The Rhizoma Atractylodis Macrocephalae adopted has effect of invigorating the spleen and replenishing QI, invigorating the spleen and regulating the stomach, dampness diuretic; The Poria adopted has effect of promoting diuresis to eliminate damp pathogen, invigorating the spleen for dissipating phlegm; The Semen Armeniacae Amarum adopted has effect of relieving cough and asthma; The Radix Platycodonis adopted has effect that lung qi dispersing eliminates the phlegm, fills blood; The Rhizoma Pinelliae adopted has effect of drying dampness to eliminate phlegm, reducing swelling and alleviating pain; The Semen Lepidii (Semen Descurainiae) adopted has effect of warming the lung eliminating phlegm promoting the circulation of QI, resolving mass and removing the obstruction of the collateral pain relieving; The Radix Stephaniae Tetrandrae adopted has effect of inducing diuresis to remove edema, wind-expelling pain-stopping; Adopt Rhizoma Zingiberis has warming spleen and stomach for dispelling cold, recuperating depleted YANG is promoted blood circulation, dampness expectorant, warming the lung to resolve fluid-retention effect; The Concha Ostreae adopted has YANG hyperactivity suppressing nourishing YIN, restrains astringent or styptic treatment for spontaneous sweating effect; The Radix Cynanchi Paniculati adopted has effect of anti-inflammatory and antalgic; The Pheretima adopted has effect of lung-clearing asthma-relieving; The Radix Glycyrrhizae adopted has effect of QI invigorating invigorating middle warmer, relieving spasm to stop pain, nourishing the lung to arrest cough, coordinating the actions of various ingredients in a prescription; The Radix Bupleuri adopted has that expelling pathogenic factors from the exterior expels the heat-evil, effect of dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy; The effect that Fructus Amomi has circulation of qi promoting seasoning, stomach function regulating is amusing adopted; The Cortex Mori adopted has effect of eliminating pathogen from the lung for relieving asthma, inducing diuresis to remove edema; Adopt Radix Salviae Miltiorrhizae there is stasis-dispelling and pain-killing, the relieving restlessness that clears away heart-fire, nourishing blood to tranquillize the mind effect.Above various raw material is organically combined by the present invention, mutually coordinates between each composition, interacts, can treating both the principal and secondary aspects of a disease to QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia, respond well, fundamentally treats this disease.For many years, by the follow-up investigation statistics to 100 these type of patients of example, show that this prescription effective percentage reaches 100%, obvious effective rate reaches 94%, and cure rate reaches 91%.
Below by the basic condition analysis to relevant data, further illustrate effect of the present invention.
Table one: general patient demographic's structure situation
Table two: curative effect situation
Enumerate three model cases below and further illustrate effect of the present invention:
1, Jiang, female, birth in 1945, from 60 years old, feels that left chest is ictally felt oppressed, pain often, and with cardiopalmus, breathe hard, the symptom such as hypopnea.After half a year, be diagnosed as QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia in here.After taking 1 course for the treatment of of this prescription, symptom is alleviated to some extent, and after 2 courses for the treatment of, symptom obviously alleviates, and after 3 courses for the treatment of, symptom disappears entirely, recovery from illness.
2, Lee, female, nineteen thirty-seven is born, and 71 years old starts, and Danzhong occurs dull pain often, sharp ache time serious, and with symptoms such as dyspnea with rapid and short breath, terrified uneasiness, pale complexion, cold spontaneous sweating.After 1 year, be diagnosed as QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia in here.After taking 1 course for the treatment of of this prescription, remission, after 2 courses for the treatment of, symptom is obviously alleviated, after take again 2 courses for the treatment of continuously, symptom disappears entirely, recovery from illness.、
3, grandson, man, nineteen fifty-one is born, and 55 years old starts, and left breast has squeezing sample angor often, and, pale tongue with white fur, deep and weak pulse timid with shortness of breath and fatigue, clear and thin sputum, dizziness and fatigue, spontaneous perspiration sound or knot generation etc. symptom.After 1 month, be diagnosed as QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia in here.After taking 1 course for the treatment of of this prescription, symptom is namely basic to disappear, after take again 1 course for the treatment of and carried out after treatment, recovery from illness.
Detailed description of the invention, for describing the present invention in detail, does further detailed description below in conjunction with specific embodiment to the present invention.
Embodiment 1: Herba Asari 3 grams, Radix Ginseng 8 grams, Ramulus Cinnamomi 8 grams, Radix Ophiopogonis 12 grams, Fructus Schisandrae Chinensis 8 grams, Fructus Trichosanthis 25 grams, the Rhizoma Atractylodis Macrocephalae 8 grams, 25 grams, Poria, 8 grams, Semen Armeniacae Amarum, Radix Platycodonis 8 grams, the Rhizoma Pinelliae 8 grams, Semen Lepidii (Semen Descurainiae) 15 grams, Radix Stephaniae Tetrandrae 10 grams, Rhizoma Zingiberis 8 grams, Concha Ostreae 25 grams, Radix Cynanchi Paniculati 12 grams, Pheretima 8 grams, 3 grams, Radix Glycyrrhizae, Radix Bupleuri 8 grams, Fructus Amomi 8 grams, Cortex Mori 8 grams, Radix Salviae Miltiorrhizae 18 grams.Above various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Embodiment 2: Herba Asari 4 grams, Radix Ginseng 9 grams, Ramulus Cinnamomi 9 grams, Radix Ophiopogonis 14 grams, Fructus Schisandrae Chinensis 9 grams, Fructus Trichosanthis 28 grams, the Rhizoma Atractylodis Macrocephalae 9 grams, 28 grams, Poria, 9 grams, Semen Armeniacae Amarum, Radix Platycodonis 9 grams, the Rhizoma Pinelliae 9 grams, Semen Lepidii (Semen Descurainiae) 16 grams, Radix Stephaniae Tetrandrae 11 grams, Rhizoma Zingiberis 9 grams, Concha Ostreae 28 grams, Radix Cynanchi Paniculati 13 grams, Pheretima 9 grams, 4 grams, Radix Glycyrrhizae, Radix Bupleuri 9 grams, Fructus Amomi 9 grams, Cortex Mori 9 grams, Radix Salviae Miltiorrhizae 19 grams.Above various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Embodiment 3: Herba Asari 5 grams, Radix Ginseng 10 grams, Ramulus Cinnamomi 10 grams, Radix Ophiopogonis 15 grams, Fructus Schisandrae Chinensis 10 grams, Fructus Trichosanthis 30 grams, the Rhizoma Atractylodis Macrocephalae 10 grams, 30 grams, Poria, 10 grams, Semen Armeniacae Amarum, Radix Platycodonis 10 grams, the Rhizoma Pinelliae 10 grams, Semen Lepidii (Semen Descurainiae) 18 grams, Radix Stephaniae Tetrandrae 12 grams, Rhizoma Zingiberis 10 grams, Concha Ostreae 30 grams, Radix Cynanchi Paniculati 15 grams, Pheretima 10 grams, 5 grams, Radix Glycyrrhizae, Radix Bupleuri 10 grams, Fructus Amomi 10 grams, Cortex Mori 10 grams, Radix Salviae Miltiorrhizae 20 grams.Above various medical material grinding is become end, then uses conventional method " whole part " to extract and make instant Chinese medicine granule, carry out subpackage according to every pouch 10 grams, airtight, preserve in shady and cool, dry place.
Claims (1)
1. treat the Chinese medicine of QI-deficiency of the heart and lung pattern of syndrome obstruction of qi in the chest and cardialgia for one kind, it is characterized in that the Chinese medicine preparation be made up of the medical material of following weight proportion: Herba Asari 3-5 parts, Radix Ginseng 8-10 parts, Ramulus Cinnamomi 8-10 parts, Radix Ophiopogonis 12-15 parts, Fructus Schisandrae Chinensis 8-10 parts, Fructus Trichosanthis 25-30 parts, the Rhizoma Atractylodis Macrocephalae 8-10 parts, 25-30 parts, Poria, 8-10 parts, Semen Armeniacae Amarum, Radix Platycodonis 8-10 parts, the Rhizoma Pinelliae 8-10 parts, Semen Lepidii (Semen Descurainiae) 15-18 parts, Radix Stephaniae Tetrandrae 10-12 parts, Rhizoma Zingiberis 8-10 parts, Concha Ostreae 25-30 parts, Radix Cynanchi Paniculati 12-15 parts, Pheretima 8-10 parts, 3-5 parts, Radix Glycyrrhizae, Radix Bupleuri 8-10 parts, Fructus Amomi 8-10 parts, Cortex Mori 8-10 parts, Radix Salviae Miltiorrhizae 18-20 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310501937.2A CN103520693B (en) | 2013-10-23 | 2013-10-23 | Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310501937.2A CN103520693B (en) | 2013-10-23 | 2013-10-23 | Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103520693A CN103520693A (en) | 2014-01-22 |
| CN103520693B true CN103520693B (en) | 2015-05-27 |
Family
ID=49923280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310501937.2A Expired - Fee Related CN103520693B (en) | 2013-10-23 | 2013-10-23 | Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103520693B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103933530A (en) * | 2014-05-06 | 2014-07-23 | 马家庆 | Traditional Chinese medicine for treating cardialgia caused by deficiency of qi yin |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1927331A (en) * | 2006-01-25 | 2007-03-14 | 宋春光 | Chinese medicine preparation for curing chronic heart failure |
| CN102441129A (en) * | 2011-12-02 | 2012-05-09 | 香河县气管炎哮喘医院 | Traditional Chinese medicine for treating chronic pulmonary heart disease |
| CN102670966A (en) * | 2012-05-29 | 2012-09-19 | 成都绿迪科技有限公司 | Chinese medicinal composition for treating dilated cardiomyopathy |
-
2013
- 2013-10-23 CN CN201310501937.2A patent/CN103520693B/en not_active Expired - Fee Related
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1334121A (en) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | Medicinal composition for restoring cardiac collaterals and its application |
| CN1927331A (en) * | 2006-01-25 | 2007-03-14 | 宋春光 | Chinese medicine preparation for curing chronic heart failure |
| CN102441129A (en) * | 2011-12-02 | 2012-05-09 | 香河县气管炎哮喘医院 | Traditional Chinese medicine for treating chronic pulmonary heart disease |
| CN102670966A (en) * | 2012-05-29 | 2012-09-19 | 成都绿迪科技有限公司 | Chinese medicinal composition for treating dilated cardiomyopathy |
Non-Patent Citations (4)
| Title |
|---|
| "中医胸痹的病因病机探讨";马伟国;《云南中医中药杂志》;20121231;第33卷(第6期);16，17 * |
| "冠心病的中医治疗";黄明安;《四川中医》;19831231(第4期);16 * |
| "胸痹心痛证辨治举隅";阎德凤等;《长春中医学院学报》;19971231;第13卷(第64期);13 * |
| "邵念方教授益气保丹饮治疗心肺气虚型胸痹经验";康日艳;《中医学报》;20101130;第25卷(第6期);1089-1090 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103520693A (en) | 2014-01-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103463568A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN103520630B (en) | A kind of Chinese medicine for the treatment of deficiency of heart-QI pattern of syndrome obstruction of qi in the chest and cardialgia | |
| CN103550710B (en) | A kind of Radix Puerariae Fructus Trichosanthis thoracic obstruction pill for the treatment of coronary heart disease | |
| CN104383460A (en) | Traditional Chinese medicine powder for treating insomnia | |
| CN104225450A (en) | Traditional Chinese medicine for treating depression | |
| CN105343395A (en) | Traditional Chinese medicine for treating spleen-deficiency and phlegm-dampness syndrome type menstrual vertigo disease | |
| CN103520693B (en) | Traditional Chinese medicine for treating heart-lung qi-deficiency syndrome type angina pectoris | |
| CN103099882A (en) | Traditional Chinese medicine composition for treating liver qi-stagnation type hyperplasia of mammary glands | |
| CN103505715B (en) | Traditional Chinese medicine for treating palpitation with syndrome of Qi deficiency of heart and gallbladder | |
| CN103520569B (en) | Traditional Chinese medicine for treatment of lumbago of syndrome of yin deficiency of liver and kidney | |
| CN103550662B (en) | Traditional Chinese medicine for treating liver and stomach incoordination type distention and fullness | |
| CN103055172A (en) | Chinese medicinal composition for treating leucoderma | |
| CN107412512A (en) | A kind of pharmaceutical composition for treating varix of lower limb | |
| CN105267862A (en) | Traditional Chinese medicine composition for treating ventricular premature beat | |
| CN105434846A (en) | Traditional Chinese medicine for treating headaches with syndromes of qi collapse and spleen deficiency | |
| CN104524535A (en) | Traditional Chinese medicine composition for treating chronic pulmonary heart disease and preparation method of traditional Chinese medicine composition | |
| CN104056196A (en) | Traditional Chinese medicine composition for treating bradycardia | |
| CN103550431B (en) | Traditional Chinese medicine for treating abdominal pain of syndrome of stagnation of liver qi and spleen deficiency | |
| CN103505605B (en) | Traditional Chinese medicine for treating palpitation disease with wind-evil syndrome | |
| CN104069427A (en) | Traditional Chinese medicine for treating palpitation | |
| CN104491237A (en) | Use of traditional Chinese medicine preparation in preparing medicines for treating primary hypertension | |
| CN103505687B (en) | Traditional Chinese medicine for treating vertigo with syndrome of heart-Qi deficiency | |
| CN103520675B (en) | Traditional Chinese medicine for treating headache disease with symptom of fettering lung by wind-cold | |
| CN105267836A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN106038716A (en) | Traditional Chinese medicine for treating yang-deficiency and cold-excessiveness syndrome type fishback-shaped carbuncles |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI ZHENFU Free format text: FORMER OWNER: SUN LI Effective date: 20150311 Owner name: LI PEIYING WANG WEI Effective date: 20150311 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Zhenfu Inventor after: Li Peiying Inventor before: Sun Li |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 215101 SUZHOU, JIANGSU PROVINCE TO: 266003 QINGDAO, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: SUN LI TO: LI ZHENFU LI PEIYING |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20150311 Address after: Department of cardiovascular surgery, Shandong province Qingdao city Jiangsu city 266003 Road, No. 16 Hospital Affiliated to Qiingdao University Applicant after: Li Zhenfu Applicant after: Li Peiying Applicant after: Wang Wei Address before: Mudu Wuzhong District Jin Feng Road Suzhou city Jiangsu province 215101 Building No. 1258 Applicant before: Sun Li |
|
| CI01 | Correction of invention patent gazette |
Correction item: Inventor Correct: Li Zhenfu|Li Peiying|Wang Wei False: Li Zhenfu|Li Peiying Number: 09 Volume: 30 |
|
| ERR | Gazette correction |
Free format text: CORRECT: INVENTOR; FROM: LI ZHENFU; LI PEIYING TO: LI ZHENFU; LI PEIYING; WANG WEI |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: LI PEIYING WANG WEI Effective date: 20150908 Owner name: AFFILIATED HOSPITAL OF QINGDAO UNIVERSITY Free format text: FORMER OWNER: LI ZHENFU Effective date: 20150908 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20150908 Address after: 266003 Jiangsu Road, Shandong, China, No. 16, No. Patentee after: Affiliated Hospital of University Of Qingdao Address before: Department of cardiovascular surgery, Shandong province Qingdao city Jiangsu city 266003 Road, No. 16 Hospital Affiliated to Qiingdao University Patentee before: Li Zhenfu Patentee before: Li Peiying Patentee before: Wang Wei |
|
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150527 Termination date: 20201023 |